Bioptix Inc news

   Watch this stock
Showing stories 1 - 10 of about 60   

Articles published

BIOP 3.39 +0.02 (0.59%)
price chart
Bioptix Reports Board of Director Changes
BOULDER, Colo., Jan. 6, 2017 /PRNewswire/ -- Bioptix, Inc. (Nasdaq: BIOP), (the "Company"), announced that Gail Schoettler, Susan Evans and David Welch have resigned from the Company's Board of Directors.
Bioptix Announces Streamlining of Workforce
20, 2017 /PRNewswire/ -- Bioptix, Inc. (Nasdaq: BIOP) ("Bioptix" or the "Company"), announced that on January 14, 2017 the Board of Directors of the Company adopted a plan under which the Company will terminate certain employees associated with the ...
Venaxis Announces Acquisition of BiOptix
13, 2016 /PRNewswire/ -- Venaxis�, Inc. (Nasdaq: APPY), announced today that it has acquired BiOptix Diagnostics, Inc., ("BiOptix") a Boulder, CO-based privately-held company. BiOptix has developed a proprietary Enhanced Surface Plasmon Resonance ...
Honig Is Buying Again: This Time, Bioptix Inc. (NASDAQ:BIOP)
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Bioptix Inc. (NASDAQ:BIOP) reported that Honig Barry C. has picked up 504,000 of common stock as of 2017-01-05.
Bioptix Inc. BiOptix, Inc. is a vitro diagnostic company. The company focuses on the commercializing of its blood-based test to serve as an adjunctive test in the diagnosis and treatment of acute appendicitis in children adolescent and young adult ...
Venaxis Reports Name Change to Bioptix, Inc and NASDAQ Ticker Symbol Change to ...
BOULDER, Colo., Dec. 8, 2016 /PRNewswire/ -- Venaxis�, Inc. (Nasdaq: APPY), announced that following the approval from shareholders at the 2016 Annual Meeting of Shareholders of the proposal to change the Company's name, the Company's name has ...
Venaxis (APPY) Changes Name to Bioptix; Will Trade Under Ticker 'BIOP'
BRIEF-Bioptix Inc files for mixed shelf offering of up to $20 million - SEC filing
March 11 Puerto Rico Governor Ricardo Rossello's revised blueprint for steering the U.S. territory out of economic crisis identifies an extra $262 million in new revenues, the governor's office announced on Saturday.
Bioptix, Inc. (NASDAQ:BIOP) Files An 8-K Entry into a Material Definitive ...
Bioptix, Inc., formerly Venaxis, Inc., provides Enhanced Surface Plasmon Resonance (SPR) platform for the detection of molecular interactions.
Bioptix, Inc. (NASDAQ:BIOP) Files An 8-K Departure of Directors or Certain ...
Bioptix, Inc. (NASDAQ:BIOP) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Bioptix sells $2.3 million in private placement
BOULDER - Bioptix Inc. (Nasdaq: BIOP) sold nearly $2.3 million of its securities in a private placement with accredited investors.
Top Decliner Inside Radar: Bioptix, Inc.'s (BIOP) stock price finalizes ...  WsNews 4investors